Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.
Luciane Cruz LopesMaribel SalasClaudia Garcia Serpa Osorio-de-CastroLisiane Freitas LealSvetlana V DoubovaMartín CañásAnahí Cristina Dreser-MansillaAngela AcostaAndré de Oliveira BaldoniCristiane de Cássia BergamaschiDaniel Marques MotaDiana-Lizbeth Gómez-GaliciaDino Sepúlveda-ViverosEdgard Narvaez DelgadoElisangela da Costa LimaFelipe Daniel VeraFelipe FerreGustavo H MarínIsmael OlmosIvan Ricardo ZimmermannIzabela FuloneJuan Roldán-SaelzerJuan Carlos Sánchez-SalgadoLucila Isabel Castro-PastranaLuiz Jupiter Carneiro de SouzaManuel Machado BeltránMarcus Tolentino SilvaMaría Belén MenaMarta Maria de França FontelesMartín Alejandro UrtasunMónica TarapuésPatricia Granja HernándezNatalia MederoRaquel Herrera-ComoglioSilvio Barberato-FilhoMarcus Tolentino SilvaVera Lúcia LuizaYared Santa-AnaL Yesenia Rodríguez-TantaMonique ElseviersPublished in: Pharmacoepidemiology and drug safety (2022)
Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable, and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication-related problems that need further exploration.